# Acacia Research Corp: overview ACTG · Nasdaq · CIK 934549 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/actg.md) · [Financials](/companies/actg/financials.md) · [Filings](/companies/actg/filings.md) · [Insiders](/companies/actg/insiders.md) Latest reported revenue: [$114.6m](/filings/0000934549-26-000034.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000934549-26-000034). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [23.3](/filings/0000934549-25-000054.md) | [48.8 d](/filings/0000934549-26-000010.md) | [124](/filings/0000934549-26-000025.md) | [51.2](/filings/0000934549-26-000034.md) | [59.4](/filings/0000934549-25-000054.md) | [50.1 d](/filings/0000934549-26-000010.md) | [54.2](/filings/0000934549-26-000025.md) | [115](/filings/0000934549-26-000034.md) | | Gross margin | % | [10.1%](/filings/0000934549-25-000054.md) | [17.6% d](/filings/0000934549-26-000010.md) | [47.4%](/filings/0000934549-26-000025.md) | [12.8%](/filings/0000934549-26-000034.md) | [21.2%](/filings/0000934549-25-000054.md) | [12.8% d](/filings/0000934549-26-000010.md) | [22.2%](/filings/0000934549-26-000025.md) | [26.8%](/filings/0000934549-26-000034.md) | | Operating margin | % | [(44.1%)](/filings/0000934549-25-000054.md) | [(32.4%) d](/filings/0000934549-26-000010.md) | [30.8%](/filings/0000934549-26-000025.md) | [(24.2%)](/filings/0000934549-26-000034.md) | [(10.8%)](/filings/0000934549-25-000054.md) | [(26.1%) d](/filings/0000934549-26-000010.md) | [(15.4%)](/filings/0000934549-26-000025.md) | [7.4%](/filings/0000934549-26-000034.md) | | Net margin | % | [(60.0%)](/filings/0000934549-25-000054.md) | [(27.5%) d](/filings/0000934549-26-000010.md) | [19.5%](/filings/0000934549-26-000025.md) | [(6.4%)](/filings/0000934549-26-000034.md) | [(4.6%)](/filings/0000934549-25-000054.md) | [6.8% d](/filings/0000934549-26-000010.md) | [(29.0%)](/filings/0000934549-26-000025.md) | [0.0%](/filings/0000934549-26-000034.md) | | Diluted EPS | $ per share | [(0.14)](/filings/0000934549-25-000054.md) | not reported | [0.25](/filings/0000934549-26-000025.md) | [(0.03)](/filings/0000934549-26-000034.md) | [(0.03)](/filings/0000934549-25-000054.md) | not reported | [(0.16)](/filings/0000934549-26-000025.md) | [0.00](/filings/0000934549-26-000034.md) | | Free cash flow | $m | [(2.8) d](/filings/0000934549-25-000054.md) | [(23.6) d](/filings/0000934549-26-000010.md) | [0.3](/filings/0000934549-26-000025.md) | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [88.0](/filings/0000934549-23-000031.md) | [59.2](/filings/0000934549-24-000023.md) | [125](/filings/0000934549-25-000004.md) | [122](/filings/0000934549-26-000010.md) | [285](/filings/0000934549-26-000010.md) | | Gross margin | % | [59.0%](/filings/0000934549-23-000031.md) | [36.9%](/filings/0000934549-24-000023.md) | [57.8%](/filings/0000934549-25-000004.md) | [24.2%](/filings/0000934549-26-000010.md) | [29.6%](/filings/0000934549-26-000010.md) | | Operating margin | % | [16.5%](/filings/0000934549-23-000031.md) | [(67.7%)](/filings/0000934549-24-000023.md) | [16.7%](/filings/0000934549-25-000004.md) | [(26.9%)](/filings/0000934549-26-000010.md) | [2.2%](/filings/0000934549-26-000010.md) | | Net margin | % | [169.5%](/filings/0000934549-23-000031.md) | [(211.2%)](/filings/0000934549-24-000023.md) | [53.6%](/filings/0000934549-25-000004.md) | [(29.5%)](/filings/0000934549-26-000010.md) | [7.6%](/filings/0000934549-26-000010.md) | | Diluted EPS | $ per share | [1.91](/filings/0000934549-23-000031.md) | [(3.13)](/filings/0000934549-24-000023.md) | [0.58](/filings/0000934549-25-000004.md) | [(0.36)](/filings/0000934549-26-000010.md) | [0.22](/filings/0000934549-26-000010.md) | | Free cash flow | $m | [13.2](/filings/0000934549-23-000031.md) | [(38.1)](/filings/0000934549-24-000023.md) | [(22.7)](/filings/0000934549-25-000004.md) | [(98.5)](/filings/0000934549-26-000010.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/actg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Starboard Value LP](/funds/1517137.md) | 2026-06-30 | $284.8m | 61,123,595 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $14.8m | 3,166,717 | | Added +61,676 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $13.7m | 2,941,723 | | Added +87,834 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $12.1m | 2,597,274 | | Added +190,907 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.9m | 1,485,187 | | Reduced −110,934 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $6.6m | 1,415,088 | | Added +7,504 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $5.5m | 1,175,163 | | Added +591,061 | | [Krilogy Financial LLC](/funds/1659047.md) | 2026-06-30 | $5.3m | 1,127,831 | | Added +344 | | [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $4.6m | 994,770 | | Reduced −96,566 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.2m | 900,809 | | Added +43,090 | ## Recent filings [All 1,490 filings](/companies/actg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-06 | 20:03 ET | [10-Q](/filings/0000934549-26-000034.md) | Quarterly report, period 2026-06-30 | 0000934549-26-000034 | | 2026-08-05 | 11:03 ET | [8-K](/filings/0000934549-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000934549-26-000031 | | 2026-06-25 | 20:08 ET | [8-K](/filings/0000934549-26-000029.md) | 5.07 Shareholder vote results | 0000934549-26-000029 | | 2026-05-07 | 20:15 ET | [10-Q](/filings/0000934549-26-000025.md) | Quarterly report, period 2026-03-31 | 0000934549-26-000025 | | 2026-05-07 | 11:23 ET | [8-K](/filings/0000934549-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000934549-26-000020 | | 2026-04-30 | 20:19 ET | [DEF 14A](/filings/0000934549-26-000016.md) | Proxy statement, period 2026-06-23 | 0000934549-26-000016 | | 2026-03-12 | 20:47 ET | [10-K](/filings/0000934549-26-000010.md) | Annual report, period 2025-12-31 | 0000934549-26-000010 | | 2026-03-11 | 11:05 ET | [8-K](/filings/0000934549-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000934549-26-000007 | | 2026-02-06 | 21:19 ET | [8-K](/filings/0000934549-26-000004.md) | 5.02 Departure or appointment of officers or directors | 0000934549-26-000004 | | 2025-11-06 | 21:20 ET | [10-Q](/filings/0000934549-25-000054.md) | Quarterly report, period 2025-09-30 | 0000934549-25-000054 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000934549-26-000010.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3ec3c5d0-0a2b-4691-9240-1b6dd4aef1b4) ## About the filer - CIK: 934549 - Tickers: ACTG - Exchange: Nasdaq - SIC code: 6794 Patent Owners & Lessors - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.